BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thorat ND, Townley HE, Patil RM, Tofail SAM, Bauer J. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer. Drug Discov Today 2020;25:1245-52. [PMID: 32371139 DOI: 10.1016/j.drudis.2020.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lynch MJ, Gobbo OL. Advances in Non-Animal Testing Approaches towards Accelerated Clinical Translation of Novel Nanotheranostic Therapeutics for Central Nervous System Disorders. Nanomaterials (Basel) 2021;11:2632. [PMID: 34685073 DOI: 10.3390/nano11102632] [Reference Citation Analysis]
2 Thorat ND, Bauer J. Functional smart hybrid nanostructures based nanotheranostic approach for advanced cancer treatment. Applied Surface Science 2020;527:146809. [DOI: 10.1016/j.apsusc.2020.146809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Ancira-cortez A, Trujillo-benítez D, Jiménez-mancilla N, Santos-cuevas C, Morales-avila E, Ferro-flores G. Synthesis and physicochemical characterization of Lu and Sm sesquioxide nanoparticles by precipitation-calcination and pulsed laser ablation in liquids. Materials Chemistry and Physics 2022;275:125229. [DOI: 10.1016/j.matchemphys.2021.125229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Della Pelle G, Kostevšek N. Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers. Int J Mol Sci 2021;22:5264. [PMID: 34067699 DOI: 10.3390/ijms22105264] [Reference Citation Analysis]
5 Khonina TG, Nikitina EY, Germov AY, Goloborodsky BY, Mikhalev KN, Bogdanova EA, Tishin DS, Demin AM, Krasnov VP, Chupakhin ON, Charushin VN. Individual iron( iii ) glycerolate: synthesis and characterisation. RSC Adv 2022;12:4042-6. [DOI: 10.1039/d1ra08485b] [Reference Citation Analysis]
6 Abbasi Kajani A, Haghjooy Javanmard S, Asadnia M, Razmjou A. Recent Advances in Nanomaterials Development for Nanomedicine and Cancer. ACS Appl Bio Mater 2021;4:5908-25. [PMID: 35006909 DOI: 10.1021/acsabm.1c00591] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Demin AM, Vakhrushev AV, Valova MS, Minin AS, Kuznetsov DK, Uimin MA, Shur VY, Krasnov VP, Charushin VN. Design of SiO2/aminopropylsilane-modified magnetic Fe3O4 nanoparticles for doxorubicin immobilization. Russ Chem Bull 2021;70:987-94. [DOI: 10.1007/s11172-021-3177-4] [Reference Citation Analysis]
8 Demin AM, Kandarakov OF, Minin AS, Kuznetsov DK, Uimin MA, Shur VY, Belyavsky AV, Krasnov VP. Modification of chemically and physically obtained Fe3O4 magnetic nanoparticles with l-Lys for cell labeling. Russ Chem Bull 2021;70:1199-208. [DOI: 10.1007/s11172-021-3205-4] [Reference Citation Analysis]
9 Khan N, Ruchika, Kumar Dhritlahre R, Saneja A. Recent advances in dual-ligand targeted nanocarriers for cancer therapy. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.04.011] [Reference Citation Analysis]
10 Demin AM, Pershina AG, Minin AS, Brikunova OY, Murzakaev AM, Perekucha NA, Romashchenko AV, Shevelev OB, Uimin MA, Byzov IV, Malkeyeva D, Kiseleva E, Efimova LV, Vtorushin SV, Ogorodova LM, Krasnov VP. Smart Design of a pH-Responsive System Based on pHLIP-Modified Magnetite Nanoparticles for Tumor MRI. ACS Appl Mater Interfaces 2021;13:36800-15. [PMID: 34324807 DOI: 10.1021/acsami.1c07748] [Reference Citation Analysis]
11 Khot VM, Salunkhe AB, Pricl S, Bauer J, Thorat ND, Townley H. Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance. Drug Discov Today 2021;26:724-39. [PMID: 33359624 DOI: 10.1016/j.drudis.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]